Andrea Canavero

Regulatory Affairs at Akero Therapeutics - South San Francisco, CA, US

Andrea Canavero's Colleagues at Akero Therapeutics
William White

CFO and Head of Corporate Development

Contact William White

Arindam Bose

Vice President, Process Development

Contact Arindam Bose

Timothy Rolph

Chief Scientific Officer

Contact Timothy Rolph

John CEP

Vice President Finance and Controller

Contact John CEP

View All Andrea Canavero's Colleagues
Andrea Canavero's Contact Details
HQ
650-487-6488
Location
Company
Akero Therapeutics
Andrea Canavero's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Andrea Canavero
Andrea Canavero currently works for Akero Therapeutics.
Andrea Canavero's role at Akero Therapeutics is Regulatory Affairs.
Andrea Canavero's email address is ***@akerotx.com. To view Andrea Canavero's full email address, please signup to ConnectPlex.
Andrea Canavero works in the Biotechnology industry.
Andrea Canavero's colleagues at Akero Therapeutics are William White, Arindam Bose, Mark Iwicki, Thomas Quinn, Timothy Rolph, Louben Dorval, John CEP and others.
Andrea Canavero's phone number is 650-487-6488
See more information about Andrea Canavero